Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-25-042724
Filing Date
2025-03-20
Accepted
2025-03-20 16:35:16
Documents
1
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 7898
  Complete submission text file 0000950170-25-042724.txt   9490
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CANDEL THERAPEUTICS, INC. 117 KENDRICK ST SUITE 450 NEEDHAM MA 02494
Business Address
Tyagarajan Seshu (Reporting) CIK: 0001923794 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40629 | Film No.: 25757001